Yingzi Cui

Dr. Yingzi Cui

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Advanced Membranes
Verified
Journal Article
Open access
SQShilong Qi
Shilong Qi
RFRong Fan
Rong Fan
XSXinwei Su
Xinwei Su
HZHao Zhang
Hao Zhang
YCYingzi Cui
Yingzi Cui
JLJianquan Luo
Jianquan Luo

5 June 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YCYingzi Cui
Yingzi Cui
QSQiaoni Shi
Qiaoni Shi
PSPu Song
Pu Song
JTJianyu Tong
Jianyu Tong
ZCZhimin Cheng
Zhimin Cheng
GGGeorge F. Fu Gao
George F. Fu Gao
Coxsackievirus A10 (CV-A10) infection, a prominent cause of childhood hand-foot-and-mouth disease (HFMD), frequently manifests with the intriguing phenomenon of onychomadesis, characterized by nail shedding. However, the underlying mechanism is elusive. Here, we found that CV-A10 infection in mice could suppress Wnt/β-catenin signaling by restraining LDL receptor–related protein 6 (LRP6) phosphorylation and β-catenin accumulation and lead to onychomadesis. Mechanistically, CV-A10 mimics Dickkopf-related protein 1 (DKK1) to interact with Kringle-containing transmembrane protein 1 (KRM1), the CV-A10 cellular receptor. We further found that Wnt agonist (GSK3β inhibitor) CHIR99021 can restore nail stem cell differentiation and protect against nail shedding. These findings provide novel insights into the pathogenesis of CV-A10 and related viruses in onychomadesis and guide prognosis assessment and clinical treatment of the disease.

17 February 2026 in Journal of Clinical Virology
Verified
Journal Article
Closed access
YCYingzi Cui
Yingzi Cui
PSPu Song
Pu Song
XZXin Zhao
Xin Zhao
ZTZhou Tong
Zhou Tong
GGGeorge F. Fu Gao
George F. Fu Gao

2 November 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
KZKe Zheng
Ke Zheng
YJYiting Jiang
Yiting Jiang
YCYingzi Cui
Yingzi Cui
XJXiaoli Ji
Xiaoli Ji
YZYuxin Zhang
Yuxin Zhang
YQYe Qiu
Ye Qiu
Coxsackievirus A16 (CVA16) is one of the major pathogens responsible for hand, foot, and mouth disease (HFMD), for which no specific antiviral therapy is currently available. Neochlorogenic acid (NCGA) and chlorogenic acid (CGA) are a pair of chiral isomers with highly similar chemical structures. While the antiviral activity of CGA has been extensively investigated, that of NCGA remains largely unexplored. In our study, we found that NCGA exhibited antiviral activity against CVA16, whereas CGA was completely inactive. Notably, NCGA also displayed extremely low cytotoxicity, and its antiviral efficacy was further confirmed in vivo. We further identified RNA-binding motif protein 24 (RBM24) as a host factor involved in the antiviral effect of NCGA against CVA16, as its knockdown attenuated the antiviral activity of NCGA. Collectively, our findings not only identify a novel natural product against CVA16 but also provide clues for the discovery of host factors involved in CVA16 infection.

Verified
Journal Article
Open access
PDF file
HLHaimeng Li
Haimeng Li
WGWenrui Gai
Wenrui Gai
HYHailan Yao
Hailan Yao
YGYuchao Gu
Yuchao Gu
YLYuyang Li
Yuyang Li
YCYingzi Cui
Yingzi Cui
Enteroviruses causing hand, foot, and mouth disease, including currently circulating Coxsackievirus A10 (CVA10) and Coxsackievirus A6 (CVA6), rely on KREMEN1 (KRM1) for cell entry, making the virus–KRM1 interface a potential target for antiviral intervention. We screened GLMarNP, an in-house library of about 3000 natural products and derivatives. Candidates targeting the KRM1 ectodomain were selected by blind docking, drug-likeness assessment, and scaffold diversity analysis. To enable high-throughput antiviral screening, we inserted eGFP into a full-length infectious CVA10 cDNA clone to generate a reporter virus designated eGFP-A10. The virus was rescued in HEK293T cells and produced robust fluorescence in RD cells over serial passages. Among 29 candidate compounds, LM-10 showed the strongest antiviral activity and exhibited low cytotoxicity. Mechanistically, LM-10 bound KRM1 and acted early in the viral life cycle. Molecular docking suggested that LM-10 binds the KR domain at a site overlapping the VP2 EF-loop contact region. KRM1 also acts as a DKK1 receptor to regulate Wnt/β-catenin signaling. LM-10 did not significantly affect this pathway in the TOP-GFP reporter assay or in transgenic zebrafish embryos. These findings establish a practical CVA10 reporter-virus platform and support steric blockade of the receptor interface as a potential antiviral strategy.